When two debilitating diseases collide: frailty and diabetic foot.

IF 1.7 4区医学 Q3 DERMATOLOGY

Journal of wound care Pub Date : 2025-04-02 DOI:10.12968/jowc.2023.0342

Hikmet Erhan Güven, Mehtap Günel, Cansu Cambaz, Hüliya Yağcioğlu, İbrahim Yilmaz, Gözde Şengül Ayçiçek

{"title":"When two debilitating diseases collide: frailty and diabetic foot.","authors":"Hikmet Erhan Güven, Mehtap Günel, Cansu Cambaz, Hüliya Yağcioğlu, İbrahim Yilmaz, Gözde Şengül Ayçiçek","doi":"10.12968/jowc.2023.0342","DOIUrl":null,"url":null,"abstract":"Objective: The purpose of this study was to determine the frailty status and contributing factors of patients who presented to our department with diabetic foot (DF).Method: Between 1 January and 30 September 2023, consecutive patients <65 years of age who presented to our outpatient clinic with DF were included in this prospective study. The Clinical Frailty Scale (CFS) was used to measure frailty at the patients' initial appointment. Based on their CFS scores, the patients were divided into two groups: non-frail patients (with a level of 1-4); and frail patients (with a level of ≥5).Results: The median age of the 97 patients included in the study was 56 years, and median follow-up period was 3.8 months. Based on their CFS levels, 36 (37.1%) patients were defined as frail. There were considerably more patients in the frail group with Wagner stages 3 and 4 DF (p<0.001). More than half of patients in the frail group required a minor amputation for their DF (52.7% compared with 24.6% in the non-frail group; p=0.005).Conclusion: DF is a debilitating disease which can lead to frailty, even in the non-geriatric population. Frailty is associated with an advanced stage of the disease and minor amputations in patients <65 years.","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 4","pages":"321-326"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of wound care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12968/jowc.2023.0342","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The purpose of this study was to determine the frailty status and contributing factors of patients who presented to our department with diabetic foot (DF).

Method: Between 1 January and 30 September 2023, consecutive patients <65 years of age who presented to our outpatient clinic with DF were included in this prospective study. The Clinical Frailty Scale (CFS) was used to measure frailty at the patients' initial appointment. Based on their CFS scores, the patients were divided into two groups: non-frail patients (with a level of 1-4); and frail patients (with a level of ≥5).

Results: The median age of the 97 patients included in the study was 56 years, and median follow-up period was 3.8 months. Based on their CFS levels, 36 (37.1%) patients were defined as frail. There were considerably more patients in the frail group with Wagner stages 3 and 4 DF (p<0.001). More than half of patients in the frail group required a minor amputation for their DF (52.7% compared with 24.6% in the non-frail group; p=0.005).

Conclusion: DF is a debilitating disease which can lead to frailty, even in the non-geriatric population. Frailty is associated with an advanced stage of the disease and minor amputations in patients <65 years.

查看原文本刊更多论文

当两种使人衰弱的疾病碰撞时：虚弱和糖尿病足。

目的：本研究的目的是确定到我科就诊的糖尿病足（DF）患者的虚弱状态及其影响因素。方法：在2023年1月1日至9月30日期间，连续患者。结果：纳入研究的97例患者中位年龄为56岁，中位随访时间为3.8个月。根据他们的CFS水平，36例（37.1%）患者被定义为虚弱。虚弱组中有相当多的患者患有Wagner期3和4期DF(结论：DF是一种使人衰弱的疾病，即使在非老年人群中也会导致虚弱。虚弱与疾病的晚期和患者的轻微截肢有关

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of wound care DERMATOLOGY-

CiteScore

2.90

自引率

10.50%

发文量

215

期刊介绍： Journal of Wound Care (JWC) is the definitive wound-care journal and the leading source of up-to-date research and clinical information on everything related to tissue viability. The journal was first launched in 1992 and aimed at catering to the needs of the multidisciplinary team. Published monthly, the journal’s international audience includes nurses, doctors and researchers specialising in wound management and tissue viability, as well as generalists wishing to enhance their practice. In addition to cutting edge and state-of-the-art research and practice articles, JWC also covers topics related to wound-care management, education and novel therapies, as well as JWC cases supplements, a supplement dedicated solely to case reports and case series in wound care. All articles are rigorously peer-reviewed by a panel of international experts, comprised of clinicians, nurses and researchers. Specifically, JWC publishes: High quality evidence on all aspects of wound care, including leg ulcers, pressure ulcers, the diabetic foot, burns, surgical wounds, wound infection and more The latest developments and innovations in wound care through both preclinical and preliminary clinical trials of potential new treatments worldwide In-depth prospective studies of new treatment applications, as well as high-level research evidence on existing treatments Clinical case studies providing information on how to deal with complex wounds Comprehensive literature reviews on current concepts and practice, including cost-effectiveness Updates on the activities of wound care societies around the world.